Geode Capital Management, LLC Axsome Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 845,407 shares of AXSM stock, worth $68.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

845,407

Previous 822,304 2.81%

Holding current value

$68.1 Million

Previous $65.4 Million 3.08%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$69.39 - $97.64 $1.6 Million - $2.26 Million	23,103 Added 2.81%	845,407 $67.5 Million
Q4 2023 Feb 13, 2024	BUY	$57.42 - $83.61 $2.52 Million - $3.66 Million	43,809 Added 5.63%	822,304 $65.4 Million
Q3 2023 Nov 13, 2023	BUY	$69.25 - $82.21 $4.76 Million - $5.65 Million	68,727 Added 9.68%	778,495 $54.4 Million
Q2 2023 Aug 11, 2023	BUY	$58.41 - $90.35 $3.35 Million - $5.18 Million	57,332 Added 8.79%	709,768 $51 Million
Q1 2023 May 15, 2023	BUY	$58.39 - $75.0 $1.63 Million - $2.09 Million	27,847 Added 4.46%	652,436 $40.2 Million

Q4 2022 Feb 13, 2023	BUY	$39.94 - $79.72 $2.48 Million - $4.94 Million	62,000 Added 11.02%	624,589 $48.2 Million
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $1.11 Million - $2.15 Million	30,837 Added 5.8%	562,589 $25.1 Million
Q2 2022 Aug 12, 2022	SELL	$21.74 - $46.75 $92,873 - $199,716	-4,272 Reduced 0.8%	531,752 $20.4 Million
Q1 2022 May 13, 2022	BUY	$23.7 - $41.39 $676,374 - $1.18 Million	28,539 Added 5.62%	536,024 $22.2 Million
Q4 2021 Feb 11, 2022	BUY	$30.7 - $43.36 $492,888 - $696,144	16,055 Added 3.27%	507,485 $19.2 Million
Q3 2021 Nov 12, 2021	BUY	$19.91 - $68.26 $162,863 - $558,366	8,180 Added 1.69%	491,430 $16.2 Million
Q2 2021 Aug 13, 2021	BUY	$50.63 - $73.5 $742,387 - $1.08 Million	14,663 Added 3.13%	483,250 $32.6 Million
Q1 2021 May 12, 2021	BUY	$55.91 - $81.44 $2.31 Million - $3.36 Million	41,286 Added 9.66%	468,587 $26.5 Million
Q4 2020 Feb 12, 2021	BUY	$66.31 - $86.52 $646,190 - $843,137	9,745 Added 2.33%	427,301 $34.8 Million
Q3 2020 Nov 13, 2020	SELL	$68.34 - $85.84 $569,477 - $715,304	-8,333 Reduced 1.96%	417,556 $29.8 Million
Q2 2020 Aug 13, 2020	BUY	$49.87 - $98.69 $730,046 - $1.44 Million	14,639 Added 3.56%	425,889 $35 Million
Q1 2020 May 14, 2020	BUY	$41.2 - $101.31 $1.78 Million - $4.38 Million	43,229 Added 11.75%	411,250 $24.2 Million
Q4 2019 Feb 13, 2020	BUY	$16.71 - $106.24 $407,473 - $2.59 Million	24,385 Added 7.1%	368,021 $38 Million
Q3 2019 Nov 12, 2019	BUY	$20.24 - $29.16 $789,339 - $1.14 Million	38,999 Added 12.8%	343,636 $6.96 Million
Q2 2019 Aug 14, 2019	BUY	$13.46 - $25.75 $1.91 Million - $3.66 Million	142,183 Added 87.52%	304,637 $7.84 Million
Q1 2019 May 14, 2019	BUY	$2.63 - $16.34 $179,494 - $1.12 Million	68,249 Added 72.45%	162,454 $2.31 Million
Q3 2017 Nov 14, 2017	BUY	$4.65 - $6.1 $100,026 - $131,217	21,511 Added 29.59%	94,205 $522,000
Q2 2017 Aug 14, 2017	BUY	N/A	72,694	72,694 $399,000

Others Institutions Holding AXSM

# of Institutions

290

Shares Held

37.1M

Call Options Held

401K

Put Options Held

464K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.45B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Axsome Therapeutics, Inc. Transaction History